Zobrazeno 1 - 10
of 43
pro vyhledávání: '"M. Springsklee"'
Publikováno v:
International Journal of Antimicrobial Agents. 6:S47-S54
An open, multicentre study was performed in hospital in-patients at a total of 12 German hospitals to investigate the efficacy and tolerability of sulbactam combined with mezlocillin, piperacillin or cefotaxime in severe bacterial infections. A total
Publikováno v:
International Journal of Antimicrobial Agents. 6:S67-S72
In a randomized, prospective study, ampicillin (AMP) in combination with the β-lactamase-inhibitor sulbactam (SBT) was compared with cefuroxime (CXM) in 73 hospitalized patients with lower respiratory tract infections. Of these patients 36 received
Autor:
M. Oberling, C.-D. Schwigon, M. Gabor, M. Springsklee, U. Schubert, J. Hartmann, H. Schwarck, R. Mössinger, J. Zinndorf
Publikováno v:
International Journal of Antimicrobial Agents. 6:S73-S77
The efficacy and tolerance of mezlocillin and ampicillin/sulbactam were investigated in an open, comparative, multicentre study involving 96 patients. The high levels of efficacy of both ampicillin/sulbactam and mezlocillin, as previously documented
Publikováno v:
Infection. 22:152-155
The question of whether ampicillin and sulbactam are able to penetrate sufficiently into costal cartilage tissue was investigated in 21 children undergoing surgery for funnel chest malformations. The concentrations of both compounds were determined i
Publikováno v:
LaboratoriumsMedizin. 14:383-386
Publikováno v:
Infection. 19:58-60
2 g ampicillin and 1 g sulbactam were given by infusion to 24 patients who were to be operated on in the ENT region. About 1 hour later during the operation samples of serum and of various tissues were taken and analysed for ampicillin and sulbactam.
Publikováno v:
Infection. 25(4)
A 45-year-old man with end-stage renal disease underwent a cadaveric kidney transplantation. The allograft had to he removed 10 days after transplantation because of an acute vascular rejection. After explantation, the patient suffered from a life-th
Publikováno v:
International journal of antimicrobial agents.
An open, multicentre study was performed in hospital in-patients at a total of 12 German hospitals to investigate the efficacy and tolerability of sulbactam combined with mezlocillin, piperacillin or cefotaxime in severe bacterial infections. A total
Publikováno v:
Infection. 22(2)
After infusion of 2 g ampicillin and 1 g sulbactam the concentrations of these two beta-lactams were determined in serum and various compartments of the respiratory tract of 22 patients. About 30 min after the end of the infusion in 15 patients the m
Publikováno v:
Medizinische Klinik (Munich, Germany : 1983). 88(1)
In a randomized prospective study, ampicillin (AMP) in combination with the beta-lactamase-inhibitor, sulbactam (SBT) was compared with cefuroxime (CXM) in 73 hospitalized patients with lower respiratory tract infections. 36 patients received SBT/AMP